Table 2.
Summary of Opioid Agonist-mGluR5 Antagonist Interactions
Probe Drug, Intrathecal | Opioid Agonist ED50 value (C.I) nmol per 5 µL |
mGluR5 antagonist ED50 value (C.I) nmol/ 5 µL |
Interaction |
---|---|---|---|
Oxymorphone + MPEP 1:2 Dose Ratio | |||
Single Drug | 3.0 (1.8–4.1) | 5.3 (3.0–7.6) | |
Observed Combination | 0.36 (0.18–0.54)* | 0.72 (0.37–1.1)* | Synergistic |
Theoretical Additive | 1.4 (0.99–1.8) | 2.8 (2.0–3.6) | |
Oxymorphamine + MPEP 1:1 Dose Ratio | |||
Single Drug | 2.2 (1.4–3.0) | 3.1 (2.2–4.0) | |
Observed Combination | 0.43 (0.26–0.60)* | 0.43 (0.26–0.60)* | Synergistic |
Theoretical Additive | 1.3 (1.0–1.6) | 1.3 (1.0–1.6) |
Significant difference from theoretical additive by Student t test, p < 0.05